Spinraza (nusinersen) is an injectable medication used to treat spinal muscular atrophy (SMA) in children and adults. This medication is injected into the spinal canal by a trained healthcare provider at a treatment facility.
Treatment of spinal muscular atrophy (SMA) in children and adults
People with spinal muscular atrophy (SMA) don't have enough of a protein called survival motor neuron (SMN), which is needed for your nerves and muscles to function properly. Spinraza (nusinersen) is an antisense oligonucleotide that helps the body make more SMN proteins to treat people with SMA.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Can be given to both children and adults of all ages
Maintenance dose only has to be given every 4 months
Medication gets injected directly into the spinal area, where movement is controlled
Must be given by injection, so it might be uncomfortable
Only given by a trained healthcare provider
Must complete blood work and urine test before each dose
Since Spinraza (nusinersen) can raise the risk of bleeding, it's important to get all of your blood work done so your provider can monitor your bleeding risk. Let your provider know if you experience any unexpected bleeding during your treatment.
Spinraza (nusinersen) can cause damage to your kidneys. It's important to get your urine tested before each treatment so your provider can monitor your kidney function.
Let your provider know if you are pregnant, planning to become pregnant, or breastfeeding because it's not known if Spinraza (nusinersen) can harm your baby.
Spinraza (nusinersen) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Spinraza (nusinersen) might raise the risk of bleeding and cause clotting problems, such as thrombocytopenia (low platelet level). Your provider will monitor your platelet levels and bleeding risk before you start your treatment with Spinraza (nusinersen) and before each dose is given. Let your provider know if you have signs and symptoms of bleeding, such as cuts or wounds that bleed for a long time, small red spots under the skin caused by blood leaking from blood vessels, discoloration of the skin caused by bleeding in the skin, nosebleeds, bleeding from your gums, blood in your urine or stool, or heavy menstrual bleeding.
Spinraza (nusinersen) might raise the risk of kidney damage, including a serious condition called glomerulonephritis. Because Spinraza (nusinersen) gets removed by the kidneys, your provider will check for the health of your kidneys before you start your treatment with Spinraza (nusinersen) and before each dose is given. Let your provider know if you experience signs of kidney damage, such as low urine amount, swelling in your legs or feet, shortness of breath, tiredness, confusion, nausea, weakness, irregular heartbeat, headache, or itchiness while on this medication.
The typical dose is 12 mg (5 mL) injected by intrathecal route (into the spinal canal).
Spinraza (nusinersen) is injected as four loading doses. The first three doses are given every 2 weeks. The fourth dose given 1 month after the third dose. After all loading doses are complete, you'll continue on a maintenance dose given once every 4 months.
Treatment of spinal muscular atrophy (SMA) in children and adults
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.